February 3, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the cough-cold categories, highlighting new products that are transforming OTC in this multi-page report.

January 7, 2015

DSN examines three of PricewaterhouseCoopers' "Top Health Industry Issues for 2015" with broad implications for the retail pharmacy industry. 

January 5, 2015

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a Q&A with Owen Mumford's Travis Shaw, in this multi-page report.

January 5, 2015

DSN senior editor Michael Johnsen examines in-depth sales activity in the vitamins, minerals and supplements and diet aid categories, highlighting new products that are transforming OTC in this multi-page report.

December 12, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.

December 5, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics, vitamins, allergy/cold/sinus medications, and incontinence, highlighting new products that are transforming OTC in this multi-page report.

November 18, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at the impact of the Hatch-Waxman act and Q&A's with industry leaders, in this multi-page report.

November 13, 2014

In the November issue of Drug Store News, we take a closer look at some of the leading women in retail pharmacy to learn what keeps them excited about the business, how they find the right work-life balance and the best advice they’ve ever received about business, leadership — and life.

November 13, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in blood-pressure monitoring kits and blood-glucose meters, highlighting new products that are transforming OTC in this multi-page report.

October 10, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, in this multi-page report.

October 10, 2014

What retail chain has more stores than any other U.S. company, with plans to open an astonishing 700 new locations this year alone, while approaching $20 billion in revenue and maintaining sales and profit momentum? It¹s Dollar General, the storied Goodlettsville, Tenn.-based small-box discount giant celebrating its 75th year in business. Download this exclusive report.

October 10, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in analgesics and digestives, highlighting new products that are transforming OTC in this multi-page report.

September 16, 2014

DSN examines chain pharmacy, including in-depth coverage of Hispanic consumers and in-store testing, in this multi-page report.

September 16, 2014

In this special diabetes report, DSN covers the latest innovation in the diabetes sector from wearable technology to prescription drugs to devices to pharmacist care for diabetic patients.

September 16, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in homeopathy and foot care, highlighting new products that are transforming OTC in this multi-page report.

August 18, 2014

DSN examines chain pharmacy, including in-depth coverage of generics and technology, in this multi-page report.

August 18, 2014

DSN senior editor Michael Johnsen examines in-depth sales activity in pain, cough-cold, overactive bladder, allergy and more, highlighting new products that are transforming OTC in this multi-page report.

July 3, 2014

DSN senior editor Michael Johnsen examines in depth sales activity in the OTC sexual wellness and first-aid categories, with extensive charts and analysis of which brands are driving growth, how summer is spiking sales of anti-itch ointments and bandages, and more in this multi-page report.

June 13, 2014

DSN senior editor Mike Johnsen examines in depth sales activity in the OTC allergy relief category, with extensive charts and analysis of which brands are driving the growth, how climate change is creating major spikes in the business and more, in this multi-page report.

September 10, 2013

Another high-quality regional pharmacy chain will soon be just a memory.

May 21, 2013

More evidence is emerging that interventions by pharmacists can have a profound beneficial effect on patient outcomes.

The latest example comes from Walgreens Specialty Pharmacy, which released the results of a study May 17 showing that more than two-thirds of patients with hepatitis C “achieved sustained virologic response or cure after completing newer ‘triple therapy’ treatment” backed up by a regimen of care and oversight by pharmacists, according to a Drug Store News report from senior editor Michael Johnsen.

Why the pharmacist interventions? They help improve patient compliance with the complicated drug therapy, which involves the administration of two newer protease inhibitors to prevent the HCV virus from reproducing, in combination with peginterferon and ribavirin. According to Johnsen, that powerful medicinal cocktail “significantly increased the cure rate and cut treatment time in half” for the 406 HCV patients in the study who received triple therapy with either telaprevir or boceprevir.

April 2, 2013

These are the days of the empowered patient — the patient who asks questions, who wants to know about how to prevent the diseases that ailed their parents or how to live more successfully with the conditions they have, who seeks and finds health information from doctors, nurses, magazines and most especially from the teeming trove of online health sites.

March 19, 2013

Last week, I wrote about Medication Therapy Management and a new bill in the House of Representatives to expand the pool of patients who qualify for MTM programs through Medicare. This week, I’m writing about – wait for it – medication therapy management.

Why? Because MTM is important, vitally important, to the future of community pharmacy, and one of the key health and prevention services that will define the profession in the era of health reform and evidence-based health care.

November 5, 2012

The opportunity for weight loss certainly hasn’t gone away — sales of diet-aid liquids were up 12.8% to $1.2 billion for the 52 weeks ended Sept. 9 across food, drug and mass (excluding Walmart), according to SymphonyIRI.